Stryker finalises Orthovita takeover.
US orthopaedic implants and medical equipment maker Stryker Corp (NYSE:SYK) on Tuesday said it had wrapped up the acquisition of orthobiologic and biosurgery products specialist Orthovita (NASDAQ:VITA).
The deal will significantly increase Strykera[euro](tm)s orthobiologics product portfolio and enhance its position in the spine, orthopaedics and biosurgery sectors, the buyer said in a press release.
The deal, worth USD3.85 (EUR2.70) per share, or a total of USD316m, was announced on 16 May.
It will have no impact on Stryker's 2011 earnings per share, the buyer added.Country: , USASector: HealthcareTarget: Orthovita IncBuyer: Stryker CorporationDeal size in USD: 316mType: Corporate acquisitionStatus: Closed
|Printer friendly Cite/link Email Feedback|
|Publication:||M & A Navigator|
|Date:||Jun 28, 2011|
|Previous Article:||LSE's CEO expects shareholders to back TMX merger.|
|Next Article:||People's United to close Danvers Bancorp buy on 30 June.|